{
    "other_tests": [
        {
            "procedure_name": "Quantitative EBV PCR",
            "date": "Day 25",
            "findings": "Highly positive results (123,000 copies/mL in blood and 1344 copies/mL in nasopharyngeal secretions)",
            "changes_over_time": "Progressive increase in EBV PCR from day 11"
        },
        {
            "procedure_name": "Immunophenotyping of peripheral lymphocytes",
            "date": "Day 26",
            "findings": "Reconstitution was essentially a reconstitution of natural killer cells with activated T cells (94% of HLA-DRâ€“positive cells)",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bronchoalveolar lavage (BAL)",
            "date": "Day 40",
            "findings": "Alveolar fluid contained 150,000 cells/mL with 69% lymphocytes, 28% macrophages, 2% neutrophils; no RBCs detected",
            "changes_over_time": "EBV identified by PCR (13,338 copies/mL) in alveolar fluid despite negative results in blood"
        },
        {
            "procedure_name": "Lymphocyte analysis",
            "date": "Day 24",
            "findings": "Confirmed 100% donor chimerism",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT scan of the lungs",
            "date": "Days 4 months and 6 months after transplantation",
            "findings": "Development of bronchectasis and hypoattenuated lung areas, indicating small airways disease",
            "changes_over_time": "Mild decrease in forced expiratory volume (to 70% of predicted value) and increase in airflow resistance and residual volume (to 156% and 143% of predicted values, respectively)"
        }
    ]
}